T1	tradename 112 126	TRIGLIDEsafely
T3	tradename 182 191	TRIGLIDE.
T5	tradename 193 201	TRIGLIDE
T7	activeingredient 203 215	fenofibrate)
T9	routeofadministration 229 233	oral
T11	fdaapprovaldate 261 265	1993
T13	tradename 346 354	Triglide
T15	indication 553 573	hypercholesterolemia
T17	indication 583 596	dyslipidemia.
T19	indication 671 692	hypertriglyceridemia.
T21	activeingredient 724 735	Fenofibrate
T23	indication 982 1002	hypertriglyceridemia
T25	indication 1013 1026	dyslipidemia:
T27	dose 1027 1033	160 mg
T29	frequency 1034 1041	per day
T31	indication 1056 1077	Hypertriglyceridemia:
T33	dose 1077 1089	50 to 160 mg
T35	frequency 1090 1097	per day
T37	dose 1209 1214	50 mg
T39	frequency 1215 1222	per day
T41	activeingredient 1682 1693	fenofibrate
T43	adversereaction 1773 1781	Myopathy
T45	adversereaction 1786 1800	rhabdomyolysis
T47	activeingredient 1839 1851	fenofibrate.
T49	adversereaction 1875 1890	muscle toxicity
T51	activeingredient 2007 2018	Fenofibrate
T53	adversereaction 2023 2052	increase serum transaminases.
T55	activeingredient 2126 2137	Fenofibrate
T57	adversereaction 2149 2183	increases serum creatinine levels.
T59	activeingredient 2262 2273	Fenofibrate
T61	adversereaction 2340 2355	cholelithiasis.
T63	adversereaction 2360 2374	cholelithiasis
T65	co-administereddrug 2478 2502	coumarin anticoagulants.
T67	adversereaction 2787 2807	abnormal liver tests
T69	adversereaction 2809 2822	increased AST
T71	adversereaction 2824 2837	increased ALT
T73	adversereaction 2839 2852	increased CPK
T75	adversereaction 2858 2867	rhinitis.
T77	company 2922 2930	Shionogi
T79	indication 3628 3648	Hypercholesterolemia
T81	indication 3658 3670	Dyslipidemia
T83	indication 3682 3702	Hypertriglyceridemia
T85	indication 3806 3826	Hypercholesterolemia
T87	indication 3836 3848	Dyslipidemia
T89	indication 3860 3880	Hypertriglyceridemia
T91	indication 4922 4942	Hypercholesterolemia
T93	indication 4994 5006	Dyslipidemia
T95	indication 5276 5296	Hypercholesterolemia
T97	indication 5306 5318	Dyslipidemia
T99	tradename 5320 5328	Triglide
T101	indication 5602 5622	hypercholesterolemia
T103	indication 5632 5645	dyslipidemia.
T105	indication 5660 5680	Hypertriglyceridemia
T107	tradename 5681 5689	Triglide
T109	indication 5783 5804	hypertriglyceridemia.
T111	activeingredient 6157 6168	fenofibrate
T113	activeingredient 6267 6278	Fenofibrate
T115	tradename 6612 6620	Triglide
T117	tradename 6674 6692	Triglide. Triglide
T119	tradename 6778 6786	Triglide
T121	indication 6870 6882	dyslipidemia
T123	indication 7028 7048	hypertriglyceridemia
T125	indication 7183 7203	hypercholesterolemia
T127	indication 7456 7477	hypertriglyceridemia.
T129	indication 7592 7613	hypertriglyceridemia.
T131	tradename 7721 7729	Triglide
T133	dose 7936 7942	160 mg
T135	frequency 7943 7954	once daily.
T137	indication 7970 7990	Hypercholesterolemia
T139	indication 8000 8012	Dyslipidemia
T141	tradename 8025 8033	Triglide
T143	dose 8037 8043	160 mg
T145	frequency 8044 8055	once daily.
T147	indication 8069 8089	Hypertriglyceridemia
T149	dose 8110 8122	50 to 160 mg
T151	frequency 8123 8131	per day.
T153	dose 8318 8324	160 mg
T155	frequency 8325 8336	once daily.
T157	tradename 8382 8390	Triglide
T159	dose 8424 8429	50 mg
T161	frequency 8430 8437	per day
T163	tradename 8613 8621	Triglide
T165	tradename 9078 9086	Triglide
T167	activeingredient 9532 9543	fenofibrate
T169	tradename 9756 9764	Triglide
T171	activeingredient 10087 10099	fenofibrate.
T173	activeingredient 10148 10159	Fenofibrate
T175	activeingredient 10867 10878	Fenofibrate
T177	activeingredient 11048 11060	fenofibrate.
T179	activeingredient 11062 11073	Fenofibrate
T181	activeingredient 11541 11552	fenofibrate
T183	tradename 11651 11659	Triglide
T185	activeingredient 11661 11672	fenofibrate
T187	tradename 11841 11850	Triglide.
T189	activeingredient 14068 14080	Fenofibrates
T191	adversereaction 14102 14110	myopathy
T193	adversereaction 14141 14156	rhabdomyolysis.
T195	adversereaction 14179 14194	muscle toxicity
T197	adversereaction 14370 14384	rhabdomyolysis
T199	co-administereddrug 14468 14505	HMG-CoA reductase inhibitor (statin).
T201	adversereaction 14703 14711	Myopathy
T203	tradename 15085 15093	Triglide
T205	adversereaction 15166 15183	myopathy/myositis
T207	adversereaction 15208 15216	myopathy
T209	adversereaction 15228 15242	rhabdomyolysis
T211	activeingredient 15268 15280	fenofibrates
T213	co-administereddrug 15301 15311	colchicine
T215	activeingredient 15362 15373	fenofibrate
T217	co-administereddrug 15379 15389	colchicine
T219	activeingredient 15443 15454	Fenofibrate
T221	adversereaction 15459 15488	increase serum transaminases
T223	activeingredient 15665 15676	fenofibrate
T225	adversereaction 15912 15938	increases in transaminases
T227	activeingredient 15950 15961	fenofibrate
T229	dose 16172 16178	134 mg
T231	dose 16182 16188	200 mg
T233	activeingredient 16189 16200	fenofibrate
T235	frequency 16201 16208	per day
T237	dose 16238 16244	160 mg
T239	tradename 16245 16254	Triglide)
T241	dose 16307 16312	34 mg
T243	dose 16316 16321	67 mg
T245	activeingredient 16333 16344	fenofibrate
T247	frequency 16345 16352	per day
T249	activeingredient 16440 16451	fenofibrate
T251	tradename 16747 16755	Triglide
T253	adversereaction 16866 16893	Serum Creatinine Elevations
T255	activeingredient 16948 16960	fenofibrate.
T257	activeingredient 17036 17048	fenofibrate.
T259	tradename 17175 17184	Triglide.
T261	tradename 17250 17258	Triglide
T263	adversereaction 17345 17359	Cholelithiasis
T265	activeingredient 17360 17371	Fenofibrate
T267	adversereaction 17468 17483	cholelithiasis.
T269	adversereaction 17488 17502	cholelithiasis
T271	tradename 17553 17561	Triglide
T273	co-administereddrug 17624 17647	Coumarin Anticoagulants
T275	tradename 17726 17734	Triglide
T277	co-administereddrug 17767 17795	coumarin-type anti-coagulant
T279	adversereaction 18165 18190	Pancreatitis Pancreatitis
T281	activeingredient 18228 18239	fenofibrate
T283	indication 18347 18367	hypertriglyceridemia
T285	adversereaction 18522 18541	Hematologic Changes
T287	activeingredient 18670 18681	fenofibrate
T289	activeingredient 18842 18854	fenofibrate.
T291	tradename 18950 18958	Triglide
T293	adversereaction 18980 19006	Hypersensitivity Reactions
T295	adversereaction 19013 19039	hypersensitivity reactions
T297	adversereaction 19048 19072	Stevens-Johnson syndrome
T299	adversereaction 19078 19104	toxic epidermal necrolysis
T301	activeingredient 19215 19228	fenofibrates.
T303	adversereaction 19231 19240	Urticaria
T305	adversereaction 19269 19273	rash
T307	activeingredient 19293 19304	fenofibrate
T309	adversereaction 19368 19394	Venothromboembolic Disease
T311	activeingredient 19507 19519	fenofibrate-
T313	activeingredient 19644 19655	fenofibrate
T315	activeingredient 19739 19750	fenofibrate
T317	activeingredient 19850 19861	fenofibrate
T319	activeingredient 21475 21486	fenofibrate
T321	activeingredient 21672 21683	fenofibrate
T323	activeingredient 21811 21822	fenofibrate
T325	activeingredient 21954 21965	Fenofibrate
T327	activeingredient 22073 22085	Fenofibrate*
T329	adversereaction 22131 22145	Abdominal Pain
T331	adversereaction 22159 22168	Back Pain
T333	adversereaction 22182 22190	Headache
T335	adversereaction 22215 22221	Nausea
T337	adversereaction 22235 22247	Constipation
T339	adversereaction 22298 22318	Abnormal Liver Tests
T341	adversereaction 22334 22347	Increased AST
T343	adversereaction 22363 22376	Increased ALT
T345	adversereaction 22390 22422	Increased Creatine Phosphokinase
T347	adversereaction 22448 22468	Respiratory Disorder
T349	adversereaction 22482 22490	Rhinitis
T351	dose 22526 22532	200 mg
T353	activeingredient 22533 22544	fenofibrate
T355	dose 22589 22595	160 mg
T357	tradename 22596 22605	Triglide.
T359	activeingredient 22758 22770	fenofibrate:
T361	adversereaction 22771 22778	myalgia
T363	adversereaction 22781 22795	rhabdomyolysis
T365	adversereaction 22797 22809	pancreatitis
T367	adversereaction 22811 22824	muscle spasms
T369	adversereaction 22826 22845	acute renal failure
T371	adversereaction 22847 22856	hepatitis
T373	adversereaction 22858 22867	cirrhosis
T375	adversereaction 22869 22875	anemia
T377	adversereaction 22877 22887	arthralgia
T379	adversereaction 22889 22897	asthenia
T381	adversereaction 22903 22945	severely depressed HDL-cholesterol levels.
T383	co-administereddrug 23176 23199	Coumarin Anticoagulants
T385	co-administereddrug 23217 23244	coumarin-type anticoagulant
T387	co-administereddrug 23338 23361	coumarin anticoagulants
T389	tradename 23392 23401	Triglide.
T391	co-administereddrug 23694 23731	Immunosuppressants Immunosuppressants
T393	co-administereddrug 23740 23752	cyclosporine
T395	co-administereddrug 23757 23767	tacrolimus
T397	adversereaction 23780 23794	nephrotoxicity
T399	tradename 23954 23962	Triglide
T401	tradename 24079 24087	Triglide
T403	co-administereddrug 24093 24111	immunosuppressants
T405	co-administereddrug 24260 24284	Bile-Acid Binding Resins
T407	co-administereddrug 24291 24315	bile acid binding resins
T409	tradename 24378 24386	Triglide
T411	co-administereddrug 24435 24458	bile acid binding resin
T413	co-administereddrug 24499 24509	Colchicine
T415	adversereaction 24520 24528	myopathy
T417	adversereaction 24540 24554	rhabdomyolysis
T419	activeingredient 24580 24592	fenofibrates
T421	co-administereddrug 24614 24624	colchicine
T423	activeingredient 24675 24686	fenofibrate
T425	co-administereddrug 24692 24703	colchicine.
T427	activeingredient 24879 24890	fenofibrate
T429	activeingredient 24910 24921	Fenofibrate
T431	routeofadministration 25049 25053	oral
T433	dose 25071 25073	15
T435	dose 25075 25077	75
T437	dose 25079 25092	and 300 mg/kg
T439	frequency 25092 25096	/day
T441	activeingredient 25100 25111	fenofibrate
T443	routeofadministration 25318 25322	oral
T445	dose 25340 25342	14
T447	dose 25344 25347	127
T449	dose 25349 25362	and 361 mg/kg
T451	frequency 25362 25366	/day
T453	dose 25479 25488	14 mg/kg/
T455	frequency 25488 25491	day
T457	routeofadministration 25676 25680	oral
T459	dose 25697 25699	15
T461	dose 25701 25704	150
T463	dose 25706 25719	and 300 mg/kg
T465	frequency 25719 25723	/day
T467	dose 25840 25849	150 mg/kg
T469	frequency 25849 25853	/day
T471	dose 25966 25974	15 mg/kg
T473	frequency 25974 25978	/day
T475	routeofadministration 26083 26087	oral
T477	dose 26105 26107	15
T479	dose 26109 26111	75
T481	dose 26113 26126	and 300 mg/kg
T483	frequency 26126 26130	/day
T485	activeingredient 26320 26331	Fenofibrate
T487	tradename 27223 27232	Triglide.
T489	tradename 27267 27275	Triglide
T491	tradename 27628 27636	Triglide
T493	tradename 27824 27833	Triglide.
T495	activeingredient 28149 28160	fenofibrate
T497	tradename 28254 28262	Triglide
T499	activeingredient 28264 28276	fenofibrate)
T501	routeofadministration 28339 28343	oral
T503	activeingredient 28400 28412	fenofibrate.
T505	activeingredient 28436 28447	fenofibrate
T507	molecularweight 28632 28638	360.83
T509	activeingredient 28640 28651	fenofibrate
T511	activeingredient 28709 28720	Fenofibrate
T513	inactiveingredient 28824 28836	crospovidone
T515	inactiveingredient 28838 28857	lactose monohydrate
T517	inactiveingredient 28859 28867	mannitol
T519	inactiveingredient 28869 28881	maltodextrin
T521	inactiveingredient 28883 28912	carboxymethylcellulose sodium
T523	inactiveingredient 28914 28926	egg lecithin
T525	inactiveingredient 28928 28949	croscarmellose sodium
T527	inactiveingredient 28951 28972	sodium lauryl sulfate
T529	inactiveingredient 28974 28999	colloidal silicon dioxide
T531	inactiveingredient 29001 29019	magnesium stearate
T533	inactiveingredient 29025 29052	monobasic sodium phosphate.
T535	tradename 29127 29135	Triglide
T537	routeofadministration 29269 29273	oral
T539	activeingredient 29292 29304	fenofibrate.
T541	activeingredient 29567 29578	fenofibrate
T543	activeingredient 30219 30230	Fenofibrate
T545	activeingredient 31081 31092	fenofibrate
T547	activeingredient 31281 31292	fenofibrate
T549	tradename 31408 31416	Triglide
T551	dose 31417 31423	160 mg
T553	dose 31496 31502	200 mg
T555	activeingredient 31503 31514	fenofibrate
T557	activeingredient 31538 31549	Fenofibrate
T559	activeingredient 31613 31624	Fenofibrate
T561	activeingredient 31798 31809	fenofibrate
T563	activeingredient 31912 31923	Fenofibrate
T565	activeingredient 32022 32033	fenofibrate
T567	activeingredient 32048 32059	fenofibrate
T569	routeofadministration 32122 32126	oral
T571	activeingredient 32217 32228	fenofibrate
T573	tmax 32402 32409	3 hours
T575	tradename 32462 32470	Triglide
T577	tradename 32569 32577	Triglide
T579	routeofadministration 32931 32935	oral
T581	activeingredient 32952 32963	fenofibrate
T583	activeingredient 33055 33066	fenofibrate
T585	activeingredient 33396 33407	fenofibrate
T587	activeingredient 33540 33551	fenofibrate
T589	activeingredient 33710 33721	fenofibrate
T591	eliminationhalflife 33875 33883	16 hours
T593	routeofadministration 34029 34033	oral
T595	activeingredient 34042 34053	fenofibrate
T597	clearance 34058 34065	1.2 L/h
T599	clearance 34085 34092	1.1 L/h
T601	tradename 34355 34363	Triglide
T603	activeingredient 34496 34508	fenofibrate.
T605	activeingredient 34567 34578	fenofibrate
T607	activeingredient 34610 34621	fenofibrate
T609	tradename 35417 35425	Triglide
T611	activeingredient 35806 35817	fenofibrate
T613	activeingredient 36188 36199	fenofibrate
T615	activeingredient 36312 36323	Fenofibrate
T617	co-administereddrug 36342 36353	Pravastatin
T619	dose 36354 36359	40 mg
T621	co-administereddrug 36378 36389	Fluvastatin
T623	dose 36390 36395	40 mg
T625	co-administereddrug 36436 36447	Glimepiride
T627	dose 36448 36452	1 mg
T629	co-administereddrug 36471 36480	Metformin
T631	dose 36481 36487	850 mg
T633	frequency 36488 36517	three times daily for 10 days
T635	co-administereddrug 36519 36532	Rosiglitazone
T637	dose 36533 36537	8 mg
T639	frequency 36538 36559	once daily for 5 days
T641	activeingredient 36571 36583	fenofibrate)
T643	activeingredient 36607 36619	fenofibrate)
T645	frequency 36646 36668	once daily for 10 days
T647	activeingredient 36670 36681	Fenofibrate
T649	activeingredient 36771 36782	Fenofibrate
T651	dose 36783 36790	160 mg1
T653	activeingredient 36870 36881	Fenofibrate
T655	dose 36882 36889	145 mg1
T657	frequency 36891 36913	once daily for 10 days
T659	activeingredient 36973 36984	Fenofibrate
T661	dose 36985 36991	54 mg1
T663	frequency 36993 37022	three times daily for 10 days
T665	activeingredient 37083 37094	Fenofibrate
T667	dose 37095 37102	145 mg1
T669	frequency 37104 37126	once daily for 14 days
T671	activeingredient 37207 37218	Fenofibrate
T673	activeingredient 37343 37354	Fenofibrate
T675	activeingredient 37417 37428	Fenofibrate
T677	dose 37429 37436	160 mg1
T679	frequency 37437 37459	once daily for 10 days
T681	activeingredient 37461 37472	Fenofibrate
T683	activeingredient 37503 37514	Fenofibrate
T685	dose 37515 37522	160 mg1
T687	activeingredient 37564 37575	Fenofibrate
T689	dose 37576 37583	145 mg1
T691	frequency 37584 37606	once daily for 10 days
T693	activeingredient 37608 37619	Fenofibrate
T695	dose 37620 37626	54 mg1
T697	frequency 37627 37657	three times daily for 10 days
T699	activeingredient 37659 37670	Fenofibrate
T701	dose 37671 37678	145 mg1
T703	frequency 37679 37701	once daily for 14 days
T705	co-administereddrug 37703 37715	Atorvastatin
T707	dose 37717 37722	20 mg
T709	frequency 37723 37745	once daily for 10 days
T711	co-administereddrug 37747 37758	Pravastatin
T713	dose 37760 37765	40 mg
T715	co-administereddrug 37784 37795	Fluvastatin
T717	dose 37797 37802	40 mg
T719	co-administereddrug 37821 37832	Glimepiride
T721	dose 37834 37838	1 mg
T723	co-administereddrug 37857 37866	Metformin
T725	dose 37868 37874	850 mg
T727	frequency 37875 37904	three times daily for 10 days
T729	co-administereddrug 37906 37919	Rosiglitazone
T731	dose 37921 37925	8 mg
T733	frequency 37926 37947	once daily for 5 days
T735	co-administereddrug 37949 37961	Atorvastatin
T737	co-administereddrug 37996 38007	Pravastatin
T739	co-administereddrug 38069 38095	3-Hydroxyl-iso-pravastatin
T741	co-administereddrug 38164 38178	5S-Fluvastatin
T743	co-administereddrug 38240 38251	Glimepiride
T745	co-administereddrug 38313 38322	Metformin
T747	co-administereddrug 38382 38395	Rosiglitazone
T749	activeingredient 38464 38476	fenofibrate)
T751	routeofadministration 38477 38481	oral
T753	activeingredient 38499 38511	fenofibrate)
T755	routeofadministration 38512 38516	oral
T757	activeingredient 38711 38723	fenofibrate.
T759	activeingredient 38783 38794	fenofibrate
T761	dose 38798 38800	10
T763	dose 38802 38818	45 and 200 mg/kg
T765	frequency 38818 38822	/day
T767	dose 38963 38972	200 mg/kg
T769	frequency 38972 38976	/day
T771	dose 39396 39411	10 and 60 mg/kg
T773	frequency 39411 39415	/day
T775	activeingredient 39697 39708	fenofibrate
T777	dose 39709 39724	10 and 60 mg/kg
T779	frequency 39724 39728	/day
T781	dose 39769 39778	400 mg/kg
T783	dose 39822 39831	250 mg/kg
T785	activeingredient 39888 39899	Fenofibrate
T787	activeingredient 40238 40249	fenofibrate
T789	dose 40250 40252	10
T791	dose 40254 40270	45 and 200 mg/kg
T793	frequency 40270 40274	/day
T795	dose 40467 40469	10
T797	dose 40471 40487	60 and 200 mg/kg
T799	frequency 40487 40491	/day
T801	activeingredient 40493 40504	fenofibrate
T803	activeingredient 40702 40713	fenofibrate
T805	activeingredient 41060 41071	Fenofibrate
T807	routeofadministration 41321 41325	oral
T809	activeingredient 41343 41354	fenofibrate
T811	dose 41511 41520	300 mg/kg
T813	frequency 41520 41524	/day
T815	indication 41637 41657	Hypercholesterolemia
T817	indication 41708 41720	Dyslipidemia
T819	activeingredient 41738 41749	fenofibrate
T821	tradename 41774 41782	Triglide
T823	dose 41783 41789	160 mg
T825	frequency 41790 41797	per day
T827	activeingredient 42043 42054	Fenofibrate
T829	activeingredient 42114 42125	Fenofibrate
T831	activeingredient 43222 43233	Fenofibrate
T833	indication 43397 43417	Hypertriglyceridemia
T835	activeingredient 43433 43444	fenofibrate
T837	indication 43815 43835	hypertriglyceridemia
T839	activeingredient 43916 43927	fenofibrate
T841	dose 43953 43959	160 mg
T843	tradename 43960 43968	Triglide
T845	frequency 43969 43976	per day
T847	activeingredient 44235 44246	Fenofibrate
T849	indication 44271 44291	Hypertriglyceridemia
T851	activeingredient 44308 44320	Fenofibrate*
T853	activeingredient 44777 44789	Fenofibrate*
T855	tradename 45288 45296	Triglide
T857	tradename 45312 45320	Triglide
T859	tradename 45916 45925	Triglide.
T861	tradename 45939 45947	Triglide
T863	activeingredient 45988 45999	fenofibrate
T865	tradename 46082 46091	Triglide.
T867	tradename 46143 46151	Triglide
T869	tradename 46454 46463	Triglide.
T871	tradename 46537 46546	Triglide.
T873	tradename 46556 46564	Triglide
T875	company 46837 46850	Shionogi Inc.
T877	company 46898 46911	Shionogi Inc.
